Corundum Open Innovation

About

Portfolio · 2

270Surgical

Specialty Laparoscopic System for Wide Cavity Visualization

1 round Latest: 2018-06

CathWorks

Noninvasive FFR Measurements for Coronary Interventions

1 round $15.8M committed Latest: 2017-10

Investment activity

1 portfolio exit on record.

Q&A

What is Corundum Open Innovation's primary investment focus?

Corundum Open Innovation is a venture capital fund that seeks to invest in promising high-tech companies in Israel at all stages of product development. The fund is backed by Japanese corporations.

Which sectors does Corundum Open Innovation primarily invest in?

Corundum Open Innovation shows a strong concentration in the Health Tech & Life Sciences sector, with all three of its listed portfolio companies and its single exit falling within this area.

Can you name a notable exit for Corundum Open Innovation?

Corundum Open Innovation had a notable exit with CathWorks, which was acquired by Medtronic for $585M in February 2026.

Who are the Managing General Partners at Corundum Open Innovation?

The Managing General Partners at Corundum Open Innovation are David Ben-Ami, Gilad Peleg, and David Heller.

What is Corundum Open Innovation's role in supporting its portfolio companies?

Corundum Open Innovation provides portfolio companies with ongoing support to ensure execution, ranging from business development to operations management.

When was Corundum Open Innovation founded?

Corundum Open Innovation was founded in 2014.

What is one of Corundum Open Innovation's recent portfolio companies?

One of Corundum Open Innovation's portfolio companies is Theranica, which focuses on neuromodulation-based patches for migraine relief and raised a Series C round.

Where are Corundum Open Innovation's offices located?

Corundum Open Innovation has offices in Israel and Japan.